Showing results (21-30 of 1,981) with videos related to
Sort By:
Pageof 199
Clinical Trials (London, England)|June 14, 2023
BASIC: A Bayesian adaptive synthetic-control design for phase II clinical trialsLiyun Jiang, Peter F Thall, Fangrong Yan, et al.Journal of the National Cancer Institute|March 30, 2019
TOP: Time-to-Event Bayesian Optimal Phase II Trial Design for Cancer ImmunotherapyRuitao Lin, Robert L Coleman, Ying YuanContemporary Clinical Trials|March 11, 2020
Keyboard design for phase I drug-combination trialsHaitao Pan, Ruitao Lin, Yanhong Zhou, et al.Biometrical Journal. Biometrische Zeitschrift|February 17, 2024
A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpointsXiaohan Chi, Ying Yuan, Zhangsheng Yu, et al.Contemporary Clinical Trials|November 27, 2020
Sample size re-estimation in adaptive enrichment designRuitao Lin, Zhao Yang, Ying Yuan, et al.Statistical Methods in Medical Research|April 4, 2024
A Bayesian quasi-likelihood design for identifying the minimum effective dose and maximum utility dose in dose-ranging studiesFeng Tian, Ruitao Lin, Li Wang, et al.International Journal of Epidemiology|May 20, 2025
Sample-size determination for decentralized clinical trialsFeng Tian, Ruitao Lin, Suyu Liu, et al.Statistics in Biopharmaceutical Research|May 5, 2025
Comb-BOIN12: A Utility-Based Bayesian Optimal Interval Design for Dose Optimization in Cancer Drug-Combination TrialsMengyi Lu, Jingyi Zhang, Ying Yuan, et al.Statistics in Medicine|March 2, 2021
uTPI: A utility-based toxicity probability interval design for phase I/II dose-finding trialsHaolun Shi, Jiguo Cao, Ying Yuan, et al.Statistical Science : a Review Journal of the Institute of Mathematical Statistics|February 15, 2011
Bayesian Models and Decision Algorithms for Complex Early Phase Clinical TrialsPeter F ThallPageof 199